Ramipril
Ramipril
17 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 48 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Ramipril
Average across 48 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 26 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 20 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 20 | SUPPLYING |
| Proficient Rx LP | unknown | 18 | SUPPLYING |
| Lupin Pharmaceuticals, Inc. | unknown | 12 | SUPPLYING |
| Chartwell RX, LLC. | unknown | 12 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 11 | SUPPLYING |
| A-S Medication Solutions | unknown | 10 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 9 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 8 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 7 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 6 | SUPPLYING |
| BluePoint Laboratories | unknown | 6 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 3 | SUPPLYING |
| GSMS, Incorporated | unknown | 3 | SUPPLYING |
+ 2 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.